GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
128.18
-1.31 (-1.01%)
At close: Sep 2, 2025, 4:00 PM
127.89
-0.29 (-0.23%)
After-hours: Sep 2, 2025, 6:31 PM EDT
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $3.68 billion as of September 2, 2025. Its market cap has increased by 304.08% in one year.
Market Cap
3.68B
Enterprise Value
3.66B
1-Year Change
304.08%
Ranking
Category
Stock Price
$128.18
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $3.68B, a decrease of -79.43%. That is a compound annual growth rate of -27.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 3.72B | 76.17% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | 20.16B | 12.65% |
| Nov 4, 2020 | 17.90B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |